Arrowhead Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $2,500 | $0 | $0 | $0 |
Gross Profit | 2,500 | -4,782 | -4,525 | |
EBITDA | -148,234 | -153,126 | -164,101 | -115,227 |
EBIT | -153,469 | -158,151 | -168,883 | -119,752 |
Net Income | -173,085 | -170,536 | -170,793 | -125,300 |
Net Change In Cash | 2,500 | 0 | 0 | 0 |
Free Cash Flow | -153,788 | -161,505 | -129,867 | -126,452 |
Cash | 53,889 | 102,685 | 69,399 | 127,704 |
Basic Shares | 124,848 | 124,478 | 124,199 | 123,285 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $3,551 | $240,735 | $243,231 | $138,287 |
Gross Profit | 3,551 | 240,735 | 243,231 | 138,287 |
EBITDA | -561,513 | -175,672 | -168,086 | -132,580 |
EBIT | -580,108 | -188,165 | -178,507 | -140,846 |
Net Income | -599,493 | -205,275 | -176,494 | -140,848 |
Net Change In Cash | 3,551 | 240,735 | 243,231 | 138,287 |
Cost of Revenue | -76,362 | 40,851 | ||
Free Cash Flow | -604,320 | -330,627 | -188,908 | 147,657 |
Cash | 102,685 | 110,891 | 108,005 | 184,434 |
Basic Shares | 119,784 | 106,750 | 105,426 | 103,745 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.39 |
2024-09-30 | -$1.37 |
2024-06-30 | -$1.38 |
2024-03-31 | -$1.02 |
